195.52
Align Technology Inc stock is traded at $195.52, with a volume of 303.85K.
It is up +1.28% in the last 24 hours and up +12.83% over the past month.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
See More
Previous Close:
$192.50
Open:
$192.78
24h Volume:
303.85K
Relative Volume:
0.25
Market Cap:
$14.03B
Revenue:
$3.98B
Net Income/Loss:
$409.56M
P/E Ratio:
35.61
EPS:
5.49
Net Cash Flow:
$630.74M
1W Performance:
+24.14%
1M Performance:
+12.83%
6M Performance:
+39.38%
1Y Performance:
-8.05%
Align Technology Inc Stock (ALGN) Company Profile
Name
Align Technology Inc
Sector
Industry
Phone
408-470-1000
Address
410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE, CA
Compare ALGN vs ISRG, BDX, RMD, MDLN, ALC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ALGN
Align Technology Inc
|
195.59 | 13.81B | 3.98B | 409.56M | 630.74M | 5.49 |
|
ISRG
Intuitive Surgical Inc
|
499.46 | 175.02B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
168.90 | 59.03B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
RMD
Resmed Inc
|
273.49 | 40.20B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
47.13 | 39.42B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
ALC
Alcon Inc
|
79.42 | 38.53B | 10.19B | 1.05B | 1.38B | 2.1044 |
Align Technology Inc Stock (ALGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Oct-10-25 | Downgrade | Jefferies | Buy → Hold |
| Jul-31-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-25-25 | Downgrade | HSBC Securities | Buy → Hold |
| Feb-14-25 | Initiated | Wells Fargo | Overweight |
| Jan-06-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Dec-04-24 | Initiated | Mizuho | Outperform |
| Oct-10-24 | Initiated | Needham | Hold |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-11-23 | Downgrade | Goldman | Neutral → Sell |
| Oct-27-23 | Downgrade | UBS | Buy → Neutral |
| Feb-02-23 | Upgrade | Goldman | Sell → Neutral |
| Jul-28-22 | Downgrade | Goldman | Buy → Sell |
| Jan-31-22 | Initiated | Morgan Stanley | Overweight |
| Jan-31-22 | Upgrade | UBS | Neutral → Buy |
| Oct-01-21 | Resumed | Credit Suisse | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-09-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Jul-08-21 | Initiated | Exane BNP Paribas | Outperform |
| Apr-22-21 | Upgrade | Berenberg | Hold → Buy |
| Jan-04-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-29-20 | Downgrade | Berenberg | Buy → Hold |
| Jul-20-20 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-09-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-24-19 | Reiterated | BofA/Merrill | Neutral |
| Oct-07-19 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-25-19 | Downgrade | Evercore ISI | Outperform → In-line |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Feb-14-19 | Downgrade | UBS | Buy → Neutral |
| Jan-17-19 | Initiated | UBS | Buy |
| Nov-20-18 | Reiterated | Credit Suisse | Outperform |
| Jul-26-18 | Reiterated | Stifel | Buy |
| Jul-13-18 | Reiterated | Stifel | Buy |
| Jun-25-18 | Resumed | BofA/Merrill | Buy |
| May-22-18 | Reiterated | Stifel | Buy |
| May-17-18 | Initiated | Evercore ISI | Outperform |
| Apr-26-18 | Reiterated | Stifel | Buy |
| Apr-20-18 | Initiated | Berenberg | Buy |
| Apr-19-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-08-18 | Initiated | Barclays | Overweight |
View All
Align Technology Inc Stock (ALGN) Latest News
Global Shift to Clear Aligners to Build a USD 99.44 Billion Market by 2034 - GlobeNewswire Inc.
Align Technology leaders drive confidence in action dialogue - Traders Union
Align Technology Shares Rise After HSBC Upgrade - marketscreener.com
Do you believe in the long-term growth potential of Align Technology (ALGN)? - MSN
Do You Believe in the Long-Term Growth Potential of Align Technology (ALGN)? - Insider Monkey
This Oracle Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday - Benzinga
Eli Lilly To Rally More Than 21%? Here Are 10 Top Analyst Forecasts For Monday - Benzinga
ALGN Stock Upgraded by HSBC: Target Price Now $200 | ALGN Stock News - GuruFocus
HSBC Upgrades Align Technology (ALGN) - Nasdaq
HSBC Upgrades Align Technology to Buy From Hold, Adjusts Price Target to $200 From $150 - marketscreener.com
Align Technology stock upgraded to Buy at HSBC on 3D printing potential - Investing.com Australia
Invisible Braces Aligners Market 2026-2033: Growth Overview, - openPR.com
A Look At Align Technology (ALGN) Valuation After Record Earnings Beat And Upgraded Outlook - simplywall.st
Why Align Technology (ALGN) Is Up 15.1% After Record 2025 Aligner Volumes And Measured 2026 Outlook - Sahm
Earnings Update: Here's Why Analysts Just Lifted Their Align Technology, Inc. (NASDAQ:ALGN) Price Target To US$195 - Yahoo Finance
Align Technology: Broad-Based Q4 Outperformance Supports Upside (NASDAQ:ALGN) - Seeking Alpha
Analysts Conflicted on These Healthcare Names: Align Tech (ALGN) and Boston Scientific (BSX) - The Globe and Mail
ALGN stock jumps again as Align Technology rides Invisalign earnings beat and fresh analyst targets - TechStock²
Piper Sandler raises Align Technology stock price target to $220 on Q4 beat By Investing.com - Investing.com South Africa
Piper Sandler raises Align Technology stock price target to $220 on Q4 beat - Investing.com
Here's Why Align Technology (ALGN) is a Strong Value Stock - Yahoo Finance
Align Technology (ALGN) Influences Positive Outlook for Envista - GuruFocus
Align Technology Q4 2025 slides reveal record revenues, international growth By Investing.com - Investing.com Australia
Orthodontic Headgear Market Outlook 2026-2033: Growth - openPR.com
Is Align Technology (ALGN) Attractive After Long Term Share Price Weakness And DCF Valuation Gap - Yahoo Finance
Align Technology Earnings Call: Record Sales, Tight Margins - TipRanks
Deep Dive Into Align Technology Stock: Analyst Perspectives (8 Ratings) - Benzinga
Align Technology Inc. stock outperforms competitors on strong trading day - MarketWatch
Research Alert: CFRA Maintains Hold Rating On Shares Of Align Technology, Inc. - 富途牛牛
Align Technology Inc (ALGN) Trading 9.78% Higher on Feb 5 - GuruFocus
ALGN: Stifel Raises Price Target to $210, Maintains Buy Rating | ALGN Stock News - GuruFocus
ALGN: Stifel Raises Price Target to $210, Maintains Buy Rating | - GuruFocus
Align Technology rallies after Q4 beat - TradingView
ALGN: UBS Maintains Neutral Rating and Raises Price Target to $1 - GuruFocus
ALGN: Wells Fargo Raises Price Target, Maintains Overweight Rati - GuruFocus
Morgan Stanley Raises Price Target for Align Technology (ALGN) t - GuruFocus
This Dental Stock Is Rising. Why Earnings Are Giving Investors a Reason to Smile. - Barron's
Align Technology Analysts Increase Their Forecasts After Upbeat Q4 Earnings - Benzinga
Baird Adjusts Price Target on Align Technology to $218 From $205, Maintains Outperform Rating - marketscreener.com
Piper Sandler Adjusts Align Technology PT to $220 From $200, Maintains Overweight Rating - marketscreener.com
Leerink Partners Adjusts Align Technology PT to $225 From $210, Maintains Outperform Rating - marketscreener.com
Mizuho Adjusts Price Target on Align Technology to $215 From $200, Maintains Outperform Rating - marketscreener.com
Align Technology, Inc. (NASDAQ:ALGN) Q4 2025 Earnings Call Transcript - Insider Monkey
Align Technology Q4 2025 revenue up 5.2% to USD 1,047.6M - Medical Buyer
Market Moves: Is Align Technology Inc benefiting from innovation trendsJuly 2025 Rallies & Entry Point Strategy Guides - baoquankhu1.vn
Morgan Stanley Raises Price Target on Align Technology to $169 From $154, Keeps Equalweight Rating - marketscreener.com
ALGN Stock Climbs on Q4 Earnings and Revenue Beat, Margins Down - Nasdaq
Align Technology stock price target raised to $210 from $200 at Stifel - Investing.com India
Align Tech Invisalign Volumes Hit Records - Benzinga
This teeth-alignment stock jumps 11%. Why earnings give investors a reason to smile. - MSN
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Align Technology Inc Stock (ALGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):